Dark

Check out our Dark Pool Levels

ELYM
Eliem Therapeutics, Inc Common Stock
stock NASDAQ

Inactive

Oct 2, 2024

5.11USD-0.969%(-0.05)803,088

Pre-market

0.00USD-100.000%(-5.16)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 18, 2022

07:00AM EST ETX-810 Phase 2a trial in diabetic peripheral neuropathic pain (DPNP) is fully enrolled GlobeNewswire Inc

Nov 9, 2021

11:06AM EST Eliem Therapeutics Q3 EPS $(0.70) Up From $(1.46) YoY Benzinga

Nov 8, 2021

04:01PM EST AdvancedETX-155 clinical development program, with the first subject successfully screened in epilepsy proof-of-concept trial and significant progress made toward the initiation of major depressive disorder (MDD) and perimenopausal depression (PMD) clinical trials GlobeNewswire Inc

Nov 4, 2021

07:00AM EDT Eliem Therapeutics to Participate at Four Upcoming Investor GlobeNewswire Inc

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Sep 13, 2021

04:15PM EDT Eliem Therapeutics Q2 EPS $(3.11), Down From $(1.12) YoY Benzinga

04:10PM EDT On track to advance two clinical programs through five proof-of-concept trials and progress two preclinical programs over the next 18-24 months GlobeNewswire Inc

Sep 7, 2021

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021 Benzinga

07:20AM EDT Guggenheim Initiates Coverage On Eliem Therapeutics with Buy Rating, Announces Price Target of $32 Benzinga

07:18AM EDT Stifel Initiates Coverage On Eliem Therapeutics with Buy Rating, Announces Price Target of $35 Benzinga

06:29AM EDT SVB Leerink Initiates Coverage On Eliem Therapeutics with Outperform Rating, Announces Price Target of $33 Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

Aug 29, 2021

09:48AM EDT The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week Benzinga

Aug 16, 2021

10:22AM EDT Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August Benzinga

Aug 15, 2021

12:16PM EDT The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

11:06AM EDT The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 10, 2021

12:59PM EDT Eliem Therapeutics Shares Open For Trade At $16.25; IPO Priced At $12.50/Share Benzinga

12:52PM EDT Eliem Therapeutics Shares Indicating $15.25 On 105K Shares Benzinga

07:55AM EDT The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts Benzinga

Aug 9, 2021

11:28PM EDT Eliem Therapeutics Prices IPO Of 6.40 Mln Shares At $12.50/shr RTTNews

Aug 6, 2021

09:38AM EDT CORRECTION: Eliem Therapeutics Not Expected To Open Today Benzinga

09:33AM EDT Eliem Therapeutics Shares Expected To Open For Trade Today Benzinga

Share